Maintenance of response to dupilumab in prurigo nodularis: A retrospective cohort study
Main Authors: | Katina J. Selvaraj, BSc, BA, MD, Thomas Stewart, MBBS, MMed, MS, John W. Frew, MBBS, MMed, MS, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | JAAD International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666328723000330 |
Similar Items
-
Dupilumab for the treatment of prurigo nodularis: A systematic review
by: Peng Cao, et al.
Published: (2023-01-01) -
Dupilumab Significantly Reduces Symptoms of Prurigo Nodularis and Depression: A Case Series
by: Louise Lönndahl, et al.
Published: (2022-08-01) -
Spontaneous resolution of intractable prurigo nodularis after subinsular cortex stroke
by: Sakeen W. Kashem, MD, PhD, et al.
Published: (2023-02-01) -
Upadacitinib for prurigo nodularis
by: Clara Muntaner-Virgili, MD, et al.
Published: (2024-06-01) -
Severe cutaneous reaction with initiation of dupilumab for atopic dermatitis and prurigo nodularis: An unusual adverse effect
by: Leore Lavin, MSc, et al.
Published: (2024-07-01)